These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

498 related items for PubMed ID: 14738151

  • 1. Effects of preactivated autologous T lymphocytes on CD80, CD86 and CD95 expression by chronic lymphocytic leukemia B cells.
    Romano C, De Fanis U, Sellitto A, Dalla Mora L, Chiurazzi F, Giunta R, Rotoli B, Lucivero G.
    Leuk Lymphoma; 2003 Nov; 44(11):1963-71. PubMed ID: 14738151
    [Abstract] [Full Text] [Related]

  • 2. Differences in constitutive and activation-induced expression of CD69 and CD95 between normal and chronic lymphocytic leukemia B cells.
    De Fanis U, Romano C, Dalla Mora L, Sellitto A, Guastafierro S, Tirelli A, Bresciano E, Giunta R, Lucivero G.
    Oncol Rep; 2003 Nov; 10(3):653-8. PubMed ID: 12684639
    [Abstract] [Full Text] [Related]

  • 3. Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells.
    Decker T, Schneller F, Sparwasser T, Tretter T, Lipford GB, Wagner H, Peschel C.
    Blood; 2000 Feb 01; 95(3):999-1006. PubMed ID: 10648415
    [Abstract] [Full Text] [Related]

  • 4. Preferential expression of B7.2 (CD86), but not B7.1 (CD80), on B cells induced by CD40/CD40L interaction is essential for anti-DNA autoantibody production in patients with systemic lupus erythematosus.
    Nagafuchi H, Shimoyama Y, Kashiwakura J, Takeno M, Sakane T, Suzuki N.
    Clin Exp Rheumatol; 2003 Feb 01; 21(1):71-7. PubMed ID: 12673892
    [Abstract] [Full Text] [Related]

  • 5. Chronic lymphocytic leukemia B cells inhibit spontaneous Ig production by autologous bone marrow cells: role of CD95-CD95L interaction.
    Sampalo A, Navas G, Medina F, Segundo C, Cámara C, Brieva JA.
    Blood; 2000 Nov 01; 96(9):3168-74. PubMed ID: 11049999
    [Abstract] [Full Text] [Related]

  • 6. Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia.
    Chu P, Deforce D, Pedersen IM, Kim Y, Kitada S, Reed JC, Kipps TJ.
    Proc Natl Acad Sci U S A; 2002 Mar 19; 99(6):3854-9. PubMed ID: 11891278
    [Abstract] [Full Text] [Related]

  • 7. Downregulation of the CD95 receptor and defect CD40-mediated signal transduction in B-chronic lymphocytic leukemia cells.
    Laytragoon-Lewin N, Duhony E, Bai XF, Mellstedt H.
    Eur J Haematol; 1998 Oct 19; 61(4):266-71. PubMed ID: 9820634
    [Abstract] [Full Text] [Related]

  • 8. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
    Costello RT, Mallet F, Sainty D, Maraninchi D, Gastaut JA, Olive D.
    Eur J Immunol; 1998 Jan 19; 28(1):90-103. PubMed ID: 9485189
    [Abstract] [Full Text] [Related]

  • 9. In vivo expression of B7-1 and B7-2 by follicular lymphoma cells can prevent induction of T-cell anergy but is insufficient to induce significant T-cell proliferation.
    Dorfman DM, Schultze JL, Shahsafaei A, Michalak S, Gribben JG, Freeman GJ, Pinkus GS, Nadler LM.
    Blood; 1997 Dec 01; 90(11):4297-306. PubMed ID: 9373240
    [Abstract] [Full Text] [Related]

  • 10. Molecular transfer of CD40 and OX40 ligands to leukemic human B cells induces expansion of autologous tumor-reactive cytotoxic T lymphocytes.
    Biagi E, Dotti G, Yvon E, Lee E, Pule M, Vigouroux S, Gottschalk S, Popat U, Rousseau R, Brenner M.
    Blood; 2005 Mar 15; 105(6):2436-42. PubMed ID: 15536147
    [Abstract] [Full Text] [Related]

  • 11. Resistance to CD95-mediated apoptosis of CD40-activated chronic lymphocytic leukemia B cells is not related to lack of DISC molecules expression.
    de Totero D, Montera M, Rosso O, Clavio M, Balleari E, Foa R, Gobbi M.
    Hematol J; 2004 Mar 15; 5(2):152-60. PubMed ID: 15048066
    [Abstract] [Full Text] [Related]

  • 12. Role of the CD40 and CD95 (APO-1/Fas) antigens in the apoptosis of human B-cell malignancies.
    Wang D, Freeman GJ, Levine H, Ritz J, Robertson MJ.
    Br J Haematol; 1997 May 15; 97(2):409-17. PubMed ID: 9163608
    [Abstract] [Full Text] [Related]

  • 13. B7 costimulatory molecules from malignant cells in patients with b-cell chronic lymphoproliferative disorders trigger t-cell proliferation.
    Trentin L, Perin A, Siviero M, Piazza F, Facco M, Gurrieri C, Galvan S, Adami F, Agostini C, Pizzolo G, Zambello R, Semenzato G.
    Cancer; 2000 Sep 15; 89(6):1259-68. PubMed ID: 11002221
    [Abstract] [Full Text] [Related]

  • 14. Altered constitutive and activation-induced expression of CD95 by B- and T-cells in B-cell chronic lymphocytic leukemia.
    De Fanis U, Dalla Mora L, Romano C, Sellitto A, Tirelli A, Lucivero G.
    Haematologica; 2002 Mar 15; 87(3):325-7. PubMed ID: 11869948
    [Abstract] [Full Text] [Related]

  • 15. Phorbol myristate acetate, but not CD40L, induces the differentiation of CLL B cells into Ab-secreting cells.
    Ghamlouch H, Ouled-Haddou H, Guyart A, Regnier A, Trudel S, Claisse JF, Fuentes V, Royer B, Marolleau JP, Gubler B.
    Immunol Cell Biol; 2014 Aug 15; 92(7):591-604. PubMed ID: 24797583
    [Abstract] [Full Text] [Related]

  • 16. In vitro engagement of CD3 and CD28 corrects T cell defects in chronic lymphocytic leukemia.
    Bonyhadi M, Frohlich M, Rasmussen A, Ferrand C, Grosmaire L, Robinet E, Leis J, Maziarz RT, Tiberghien P, Berenson RJ.
    J Immunol; 2005 Feb 15; 174(4):2366-75. PubMed ID: 15699173
    [Abstract] [Full Text] [Related]

  • 17. Effect of serum and antioxidants on the immunogenicity of protein kinase C-activated chronic lymphocytic leukemia cells.
    Hammond C, Shi Y, Mena J, Tomic J, Cervi D, He L, Millar AE, Debenedette M, Schuh AC, Baryza JL, Wender PA, Radvanyi L, Spaner DE.
    J Immunother; 2005 Feb 15; 28(1):28-39. PubMed ID: 15614042
    [Abstract] [Full Text] [Related]

  • 18. CD40 activation of carcinoma cells increases expression of adhesion and major histocompatibility molecules but fails to induce either CD80/CD86 expression or T cell alloreactivity.
    Vonderheide RH, Butler MO, Liu JF, Battle TE, Hirano N, Gribben JG, Frank DA, Schultze JL, Nadler LM.
    Int J Oncol; 2001 Oct 15; 19(4):791-8. PubMed ID: 11562757
    [Abstract] [Full Text] [Related]

  • 19. Role of CD80, CD86, and CTLA4 on mouse CD4(+) T lymphocytes in enhancing cell-cycle progression and survival after activation with PMA and ionomycin.
    Mukherjee S, Maiti PK, Nandi D.
    J Leukoc Biol; 2002 Nov 15; 72(5):921-31. PubMed ID: 12429713
    [Abstract] [Full Text] [Related]

  • 20. Immunostimulatory CpG-oligonucleotides induce functional high affinity IL-2 receptors on B-CLL cells: costimulation with IL-2 results in a highly immunogenic phenotype.
    Decker T, Schneller F, Kronschnabl M, Dechow T, Lipford GB, Wagner H, Peschel C.
    Exp Hematol; 2000 May 15; 28(5):558-68. PubMed ID: 10812246
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.